<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: Ethics of Biological Integration & Safety | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #ffffff;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 8px 0;
 text-decoration: none;
 color: #374151;
 font-size: 15px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 32px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

.welcome-box p {
 margin: 0;
 font-size: 17px;
 color: #44403c;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 32px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 margin-bottom: 20px;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 border-left: 5px solid #722F37;
}

.case-study-header {
 background: #f9fafb;
 padding: 20px 28px;
 border-bottom: 1px solid #e5e7eb;
}

.case-study-header .title {
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

/* MODULE CONNECTION */
.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

.module-connection p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 22: L2: Ethical Considerations</span>
 <h1 class="lesson-title">Ethics of Biological Integration & Safety</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">⏱️ 15 min read</span>
 <span class="meta-badge">ASI Certified Content</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">A</div>
 <div class="asi-text">
 <div class="asi-text"><span class="label">Verified Excellence</span></div>
 <div class="asi-title">AccrediPro Standards Institute (ASI) Curriculum</div>
 </div>
 </div>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Building on Your Foundation:</strong> In the previous lesson, we explored <em>Informed Consent</em>. Now, we apply those ethical frameworks to the most critical technical phase of the H.E.R.B.A.L. Method™: <strong>B - Biological Integration</strong>, where safety meets science.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to Lesson 3. For many of our students—especially those transitioning from careers in nursing, teaching, or corporate leadership—the transition to clinical herbalism brings a profound sense of responsibility. This lesson focuses on the <strong>Duty of Care</strong> regarding safety. We will explore the ethical necessity of screening for interactions, transparency in formulation, and the professional protocols required for adverse event reporting. Your legitimacy as a practitioner rests on your ability to keep clients safe in a complex pharmacological world.</p>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#duty-of-care"><span class="section-num">1</span>The Duty of Care in Biological Integration</a></li>
 <li><a href="#screening-hdi"><span class="section-num">2</span>Ethical Screening for Interactions</a></li>
 <li><a href="#transparency"><span class="section-num">3</span>Transparency in Formulation & Ingredients</a></li>
 <li><a href="#adverse-events"><span class="section-num">4</span>Adverse Event Reporting (AER) Ethics</a></li>
 <li><a href="#collaboration"><span class="section-num">5</span>Guidelines for Professional Collaboration</a></li>
 </ul>
 </nav>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define the clinical "Duty of Care" specifically within the context of Biological Integration (B).</li>
 <li>Establish a rigorous ethical protocol for screening Herb-Drug-Nutrient interactions (HDIs).</li>
 <li>Execute full transparency regarding solvents, excipients, and fillers in botanical formulations.</li>
 <li>Implement professional Adverse Event Reporting (AER) procedures for client safety and public health.</li>
 <li>Navigate the ethics of communicating with medical teams regarding potential contraindications.</li>
 </ul>
 </div>

 <h2 id="duty-of-care">The Duty of Care in Biological Integration</h2>
 <p>In clinical practice, the <strong>Duty of Care</strong> is a legal and ethical obligation to avoid acts or omissions (which could be reasonably foreseen) that would be likely to harm your client. In the context of the H.E.R.B.A.L. Method™, this duty is most intensely focused on the <strong>"B" - Biological Integration</strong> phase.</p>

 <p>While a hobbyist might suggest a tea for relaxation, a <strong>Certified Clinical Herbalist™</strong> must evaluate how that tea's phytochemicals interact with the client's current pharmaceutical load, their metabolic health, and their genetic predispositions. Failing to screen for these factors isn't just a technical error; it is an <span class="highlight">ethical breach</span> of the therapeutic relationship.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p>Think of your safety screening as the "Insurance of Trust." When you show a client that you have cross-referenced their five medications against your proposed protocol, you aren't just being safe—you're establishing yourself as a high-level professional worthy of their investment.</p>
 </div>

 <h2 id="screening-hdi">Ethical Screening for Interactions</h2>
 <p>Ethical practice requires more than a "quick search." It requires a systematic approach to identifying potential <strong>Herb-Drug Interactions (HDIs)</strong>. A 2021 study indicated that nearly 25% of patients taking prescription medications also use herbal supplements, yet only a fraction of these interactions are caught by primary care physicians.</p>

 <p>Your ethical obligation includes screening for:</p>
 <ul>
 <li><strong>Pharmacodynamic Interactions:</strong> Where the herb and drug have similar or opposing effects (e.g., combining Valerian with Benzodiazepines).</li>
 <li><strong>Pharmacokinetic Interactions:</strong> Where the herb affects how the drug is absorbed, distributed, metabolized (CYP450 enzymes), or excreted (e.g., St. John's Wort and the P-glycoprotein pathway).</li>
 </ul>

 <table class="data-table">
 <thead>
 <tr>
 <th>Drug Class</th>
 <th>Common Herbal Interaction</th>
 <th>Ethical Consideration</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Anticoagulants (Warfarin)</td>
 <td><em>Salvia miltiorrhiza</em> (Dan Shen)</td>
 <td>High risk of hemorrhage; mandatory referral/monitoring.</td>
 </tr>
 <tr>
 <td>Immunosuppressants</td>
 <td><em>Echinacea spp.</em></td>
 <td>Potential to counteract drug efficacy; avoid in transplant cases.</td>
 </tr>
 <tr>
 <td>SSRIs / Antidepressants</td>
 <td><em>Hypericum perforatum</em></td>
 <td>Serotonin syndrome risk; requires strict titration or avoidance.</td>
 </tr>
 <tr>
 <td>Statins</td>
 <td><em>Citrus paradisi</em> (Grapefruit)</td>
 <td>Metabolic pathway inhibition leading to toxicity.</td>
 </tr>
 </tbody>
 </table>

 <div class="case-study">
 <div class="case-study-header">
 <span class="title">Case Study: The "Safe" Supplement Mistake</span>
 </div>
 <div class="case-study-content">
 <p><strong>Practitioner:</strong> Diane (54), a former educator now in private practice.<br>
 <strong>Client:</strong> Margaret (62), on high-dose blood pressure medication and a mild sedative.<br>
 <strong>The Scenario:</strong> Margaret requested a strong Nervine formula for sleep. Diane, focused on the "E" (Energetic) assessment, suggested a high-dose Valerian and Passionflower tincture. She failed to cross-reference the sedative medication (B-phase).<br>
 <strong>Outcome:</strong> Margaret experienced extreme dizziness and a fall the next morning due to excessive CNS depression.<br>
 <strong>Ethical Lesson:</strong> Diane realized that "natural" does not mean "free of interaction." She updated her intake form to include a mandatory "Medication Reconciliation" section before any remedy selection.</p>
 </div>
 </div>

 <h2 id="transparency">Transparency in Formulation & Ingredients</h2>
 <p>Ethical formulation goes beyond the primary herb. As a clinician, you must be transparent about <strong>everything</strong> in the bottle. This includes solvents (ethanol, glycerin, vinegar), excipients in capsules (magnesium stearate, silica), and even the source of the capsule shell (gelatin vs. cellulose).</p>

 <p>Why does this matter ethically?</p>
 <ul>
 <li><strong>Allergies:</strong> A client might be allergic to the corn source of the ethanol used in a tincture.</li>
 <li><strong>Religious/Ethical Beliefs:</strong> Gelatin capsules are inappropriate for vegans or those following Halal/Kosher diets.</li>
 <li><strong>Recovery:</strong> Using high-ethanol tinctures for a client in recovery for alcohol use disorder without disclosure is a severe ethical violation.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p>Always list your solvents on your labels. Instead of just "Tincture," use "Hydro-ethanolic extract (Organic Cane Alcohol 50%, Distilled Water 50%)." This level of detail separates the amateur from the clinical professional.</p>
 </div>

 <h2 id="adverse-events">Adverse Event Reporting (AER) Ethics</h2>
 <p>An <strong>Adverse Event (AE)</strong> is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product or herbal remedy. Ethically, you cannot simply "wait for it to go away."</p>

 <p>Your responsibilities include:</p>
 <ol>
 <li><strong>Documentation:</strong> Record the exact dosage, timing, symptoms, and duration of the event in the client's file.</li>
 <li><strong>Causality Assessment:</strong> Use the Naranjo Scale or similar tools to determine if the herb likely caused the event.</li>
 <li><strong>Reporting:</strong> If you are using a commercial product, you have an ethical (and often legal) duty to report the event to the manufacturer. In the US, serious events should be reported via the FDA's MedWatch program.</li>
 </ol>

 <p><span class="highlight">Stat Check:</span> A meta-analysis of herbal safety found that while serious adverse events are rare (less than 1% in most controlled studies), 60% of minor events go unreported, hindering our collective knowledge of botanical safety.</p>

 <h2 id="collaboration">Guidelines for Professional Collaboration</h2>
 <p>When you identify a potential safety risk between an herb and a drug, how do you handle it? Ethically, you must <strong>never</strong> tell a client to stop taking a prescribed medication. This is outside your scope of practice and highly dangerous.</p>

 <p><strong>The Ethical Collaboration Protocol:</strong></p>
 <ul>
 <li><strong>Step 1:</strong> Inform the client of the potential interaction found in the literature.</li>
 <li><strong>Step 2:</strong> Provide the client with a professional "Summary of Concern" they can take to their doctor.</li>
 <li><strong>Step 3:</strong> Offer to speak directly with the physician or pharmacist if the client provides a signed release.</li>
 <li><strong>Step 4:</strong> If the risk is high and the client refuses to consult their doctor, you must ethically decline to provide that specific herbal protocol.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p>When writing to a doctor, use "Clinical Language." Instead of saying "This herb is better than the drug," say "Current literature suggests a potential pharmacokinetic interaction via the CYP3A4 pathway. I would appreciate your clinical perspective on co-administration safety for our mutual client."</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is screening for the "B" phase (Biological Integration) considered an ethical "Duty of Care"?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Because it involves the predictable safety of the client. As a clinician, you have a moral and professional obligation to prevent foreseeable harm caused by herb-drug interactions or metabolic contraindications.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. If a client is in recovery for alcohol use, what is the ethical requirement regarding tincture formulation?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Full transparency regarding the ethanol content is mandatory. Ethically, you should offer non-alcoholic alternatives (glycerites, acetums, or teas) and allow the client to make an informed choice.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the practitioner's responsibility if a client experiences a serious unexpected reaction to a retail herbal product?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The practitioner must document the event, assess causality, and report the event to the manufacturer and/or regulatory bodies (like the FDA MedWatch) to ensure public safety and product quality control.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. True or False: If you find a potential interaction, you should tell the client to lower their medication dose so they can take the herb.</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">False. Adjusting pharmaceutical dosages is outside the herbalist's scope of practice. The ethical path is to refer the client back to their prescribing physician to discuss the interaction.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <span class="box-label">Key Takeaways</span>
 <ul>
 <li><strong>Safety is an Ethical Pillar:</strong> The Biological Integration (B) phase of the H.E.R.B.A.L. Method™ is where clinical ethics are most vital.</li>
 <li><strong>Rigorous Screening:</strong> Use professional databases to screen for both pharmacodynamic and pharmacokinetic interactions.</li>
 <li><strong>Total Transparency:</strong> Disclose all solvents, fillers, and capsule materials to respect client autonomy and safety.</li>
 <li><strong>AER is Mandatory:</strong> Reporting adverse events is a service to the profession and the public.</li>
 <li><strong>Respect Scope:</strong> Collaborate with medical professionals rather than overriding their prescriptions.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Boullata, J. I., & Armenti, V. T. (2010). <em>Handbook of Drug-Nutrient Interactions.</em> Humana Press.</li>
 <li>Gardiner, P., et al. (2007). "The Safety of Herbal Supplements: A Guide for Practitioners." <em>Journal of Family Practice.</em></li>
 <li>American Herbal Products Association (AHPA). (2020). "Guidance on Adverse Event Reporting for Botanical Dietary Supplements."</li>
 <li>Sood, A., et al. (2008). "Potential for Herb-Drug Interactions in Adult Medical Oncology Patients." <em>Supportive Care in Cancer.</em></li>
 <li>Brinker, F. (2010). <em>Herbal Contraindications and Drug Interactions.</em> Eclectic Medical Publications.</li>
 <li>World Health Organization (WHO). (2004). "WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems."</li>
 </ol>
 </div>
</div>

<script>
document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
});
</script>

</body>
</html>